EUVIMEDEUVIMED entdecken
Multizentrische Studie

Las dislipidemias y su tratamiento en centros de alta complejidad en Colombia

Álvaro J Ruiz, Hernando Vargas-Uricoechea, Miguel Urina-Triana, Alejandro Román-González, Daniel Isaza, Edwin Etayo, Adalberto Quintero, Dora Inés Molina, Juan Manuel Toro, Gustavo Parra, Alonso Merchán, Alberto Cadena und 9 weitere

Clínica e Investigación en Arteriosclerosis · 2020-05 · 32 (3) · 101-110

DOI: 10.1016/j.arteri.2019.11.005 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clínica e Investigación en Arteriosclerosis, 2020-05. Verfasst von Álvaro J Ruiz und 20 weiteren Autor:innen. Beteiligte Einrichtung: Pontificia Universidad Javeriana, Bogotá, Colombia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: Data is scarce on the distribution of different types of dyslipidaemia in Colombia. The primary objective was to describe the frequency of dyslipidaemias. The secondary objectives were: frequency of cardiovascular comorbidity, statins and other lipid-lowering drugs use, frequency of statins intolerance, percentage of patients achieving c-LDL goals, and distribution of cardiovascular risk (CVR). MATERIALS AND METHODS: Cross-sectional study with retrospective data collection from 461 patients diagnosed with dyslipidaemia and treated in 17 highly specialised centres distributed into six geographic and economic regions of Colombia. RESULTS: Mean (SD) age was 66.4 (±12.3) years and 53.4% (246) were women. Dyslipidaemias were distributed as follows in order of frequency: mixed dyslipidaemia (51.4%), hypercholesterolaemia (41.0%), hypertriglyceridaemia (5.4%), familial hypercholesterolaemia (3.3%), and low c-HDL (0.7%). The most prescribed drugs were atorvastatin (75.7%) followed by rosuvastatin (24.9%). As for lipid control, 55% of all patients, and 28.6% of those with coronary heart disease, did not achieve their personal c-LDL goal despite treatment. The frequency of statin intolerance was 2.6% in this study. CONCLUSIONS: Mixed dyslipidaemia and hypercholesterolaemia are the most frequent dyslipidaemias in Colombia. A notable percentage of patients under treatment with lipid-lowering drugs, including those with coronary heart disease, did not achieve specific c-LDL goals. This poor lipid control may worsen patient's CVR, so that therapeutic strategies need to be changed, either with statin intensification or addition of new drugs in patients with higher CVR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgedAged, 80 and overCholesterol, LDLColombiaCross-Sectional StudiesDyslipidemiasFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsMaleMiddle AgedRetrospective Studies

Stichwörter der Autor:innen

AterosclerosisAtherosclerosisCardiovascular diseaseDislipidemiaDyslipidaemiaEnfermedad cardiovascularEstatinasFamilial hypercholesterolaemiaHipercolesterolemia familiarStatins

Substanzen

Cholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents

Autor:innen und Institutionen

  • Pontificia Universidad Javeriana, Bogotá, Colombia.
  • Universidad del Cauca, Popayán, Colombia. Electronic address: hernandovargasuricoechea@gmail.com.
  • Fundación del Caribe para la Investigación Biomédica-Facultad de Ciencias de la Salud, Universidad Simón Bolívar, Barranquilla, Colombia.
  • Hospital Universitario San Vicente Fundación-Universidad de Antioquia, Medellín, Colombia.
  • Fundación Cardioinfantil, Bogotá, Colombia.
  • Consultorio privado, Cali, Colombia.

Zitieren

APA

Ruiz, Á. J., Vargas-Uricoechea, H., Urina-Triana, M., Román-González, A., Isaza, D., Etayo, E., Quintero, A., Molina, D. I., Toro, J. M., Parra, G., Merchán, A., Cadena, A., Yupanqui Lozano, H., Cárdenas, J. M., Quintero, Á. M., Botero, R., Jaramillo, M., Arteaga, J. M., Vesga-Angarita, B., …, & Betancur-Valencia, M. (2020). Las dislipidemias y su tratamiento en centros de alta complejidad en Colombia. Clínica e Investigación en Arteriosclerosis, 32(3), 101-110. https://doi.org/10.1016/j.arteri.2019.11.005

Vancouver

Ruiz ÁJ, Vargas-Uricoechea H, Urina-Triana M, Román-González A, Isaza D, Etayo E, et al. Las dislipidemias y su tratamiento en centros de alta complejidad en Colombia. Clínica e Investigación en Arteriosclerosis. 2020;32(3):101-110. doi:10.1016/j.arteri.2019.11.005

BibTeX
@article{Ruiz2020,
  author = {Ruiz, Álvaro J and Vargas-Uricoechea, Hernando and Urina-Triana, Miguel and Román-González, Alejandro and Isaza, Daniel and Etayo, Edwin and Quintero, Adalberto and Molina, Dora Inés and Toro, Juan Manuel and Parra, Gustavo and Merchán, Alonso and Cadena, Alberto and Yupanqui Lozano, Hernán and Cárdenas, Juan Mauricio and Quintero, Álvaro Mauricio and Botero, Rodrigo and Jaramillo, Mónica and Arteaga, Juan Manuel and Vesga-Angarita, Boris and Valenzuela-Plata, Etna and Betancur-Valencia, Mónica},
  title = {Las dislipidemias y su tratamiento en centros de alta complejidad en Colombia},
  journal = {Clínica e Investigación en Arteriosclerosis},
  year = {2020},
  volume = {32},
  number = {3},
  pages = {101--110},
  doi = {10.1016/j.arteri.2019.11.005}
}
Kostenlos starten →